Ann: Strategy Update - ATL1103 & ATL1102, page-17

Sounds very exiting to me. Mark and Co are now confident enough to take the partnering program to the next step. As I mentioned before it's about bargaining power, and they would not engage Destum before they had what they needed.

From the destum site:

'We have successfully completed fourteen (14) transactions since 2010 to include deals with major pharmaceutical companies such as Boehringer Ingelheim, Eli Lilly, Johnson & Johnson, Novartis, Pfizer, and Sanofi.'

Destum has the contacts, it's all business and legal from here.